Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Nagge

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Canadian Family Physician Medecin De Famille Canadien|January 23, 2016
Different perspective on ASA useJeff Nagge, Jillian Bauer
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 14, 2024
Identifying pseudo-resistant hypertension and optimizing diuretic therapy for confirmed resistant cases in primary careJoey Champigny, Jeff Nagge
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|March 11, 2024
The quality of pharmacist-led community warfarin management across 2 provinces in Canada: A cross-sectional observational studyLaura Morrison, Jeff Nagge
Canadian Family Physician Medecin De Famille Canadien|April 14, 2019
Simplifying QT prolongation for busy cliniciansKelly A Grindrod, Jeff Nagge
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|May 24, 2016
QT ProlongationKelly Grindrod, Jeff Nagge, Adrian Poon
Archives of Internal Medicine|December 3, 2002
Is impaired renal function a contraindication to the use of low-molecular-weight heparin?Jeff Nagge, Mark Crowther, Jack Hirsh
Canadian Family Physician Medecin De Famille Canadien|October 13, 2019
Managing hypertension in primary careKhrystine Waked, Jeff Nagge, Kelly Grindrod
American Heart Journal|May 3, 2005
Evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairmentJeff Nagge, Olavo Fernandes, Jin Huh
Canadian Family Physician Medecin De Famille Canadien|April 14, 2022
Variation in bleeding risk estimates among online calculators: Cross-sectional study of apps used by and for patients with atrial fibrillationRyan Pelletier, Jeff Nagge, John-Michael Gamble
Canadian Family Physician Medecin De Famille Canadien|January 1, 2015
Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient settingVikas Srinivasan Sridhar, Philemon Leung, Nicole Seymour, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Canadian Family Physician Medecin De Famille Canadien|January 23, 2016
Different perspective on ASA useJeff Nagge, Jillian Bauer
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 14, 2024
Identifying pseudo-resistant hypertension and optimizing diuretic therapy for confirmed resistant cases in primary careJoey Champigny, Jeff Nagge
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|March 11, 2024
The quality of pharmacist-led community warfarin management across 2 provinces in Canada: A cross-sectional observational studyLaura Morrison, Jeff Nagge
Canadian Family Physician Medecin De Famille Canadien|April 14, 2019
Simplifying QT prolongation for busy cliniciansKelly A Grindrod, Jeff Nagge
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|May 24, 2016
QT ProlongationKelly Grindrod, Jeff Nagge, Adrian Poon
Archives of Internal Medicine|December 3, 2002
Is impaired renal function a contraindication to the use of low-molecular-weight heparin?Jeff Nagge, Mark Crowther, Jack Hirsh
Canadian Family Physician Medecin De Famille Canadien|October 13, 2019
Managing hypertension in primary careKhrystine Waked, Jeff Nagge, Kelly Grindrod
American Heart Journal|May 3, 2005
Evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairmentJeff Nagge, Olavo Fernandes, Jin Huh
Canadian Family Physician Medecin De Famille Canadien|April 14, 2022
Variation in bleeding risk estimates among online calculators: Cross-sectional study of apps used by and for patients with atrial fibrillationRyan Pelletier, Jeff Nagge, John-Michael Gamble
Canadian Family Physician Medecin De Famille Canadien|January 1, 2015
Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient settingVikas Srinivasan Sridhar, Philemon Leung, Nicole Seymour, et al.
Pageof 2